Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel
- PMID: 8251766
- DOI: 10.1016/s0169-6009(08)80225-5
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel
Abstract
Osteopontin is a phosphorylated bone matrix sialoprotein, postulated to play a regulatory role in biomineralization. The effects of a crude preparation of rat bone osteopontin and a more highly purified bovine bone osteopontin were evaluated using a gel diffusion system to measure effects of 0.1-100 micrograms/ml of this matrix protein on hydroxyapatite formation and crystal proliferation. Bovine osteopontin at concentrations greater than 25 micrograms/ml inhibited both hydroxyapatite formation and growth in a dose-dependent manner. Osteopontin at concentrations lower than 25 micrograms/ml had no detectable effect on the amount of mineral accumulated in experiments with and without pre-formed hydroxyapatite seed crystals either when initial mineral deposition was assessed at 3.5 days, or when mineral formation and growth were assessed at 5 days. There was a statistically significant dose-dependent decrease in crystal length at all concentrations tested. The rat osteopontin preparation had similar inhibitory abilities. Partial dephosphorylation of bovine osteopontin with alkaline phosphatase removed its inhibitory ability, and reduced its ability to bind calcium. The affinity of bovine osteopontin for hydroxyapatite was determined based on a Langmuir adsorption isotherm, with values of K (binding affinity) and N (number of binding sites) being 0.026 ml/microgram and 1084 micrograms/m2, respectively. The data suggest that, in this system, osteopontin is an effective inhibitor of hydroxyapatite formation and growth due to its affinity for the hydroxyapatite crystals. In this system, osteopontin, distinct from other phosphoproteins which both promote and inhibit hydroxyapatite deposition, did not enhance mineral formation at any concentration tested.
Similar articles
-
Dentin sialoprotein (DSP) has limited effects on in vitro apatite formation and growth.Calcif Tissue Int. 2000 Dec;67(6):472-8. doi: 10.1007/s002230001169. Calcif Tissue Int. 2000. PMID: 11289697
-
Nucleation of hydroxyapatite by bone sialoprotein.Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8562-5. doi: 10.1073/pnas.90.18.8562. Proc Natl Acad Sci U S A. 1993. PMID: 8397409 Free PMC article.
-
Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation.Biochem J. 1994 Jun 15;300 ( Pt 3)(Pt 3):723-8. doi: 10.1042/bj3000723. Biochem J. 1994. PMID: 8010953 Free PMC article.
-
Role of osteopontin in modulation of hydroxyapatite formation.Calcif Tissue Int. 2013 Oct;93(4):348-54. doi: 10.1007/s00223-013-9698-6. Epub 2013 Jan 19. Calcif Tissue Int. 2013. PMID: 23334303 Review.
-
Osteopontin and related phosphorylated sialoproteins: effects on mineralization.Ann N Y Acad Sci. 1995 Apr 21;760:249-56. doi: 10.1111/j.1749-6632.1995.tb44635.x. Ann N Y Acad Sci. 1995. PMID: 7785899 Review.
Cited by
-
Embracing Mechanobiology in Next Generation Organ-On-A-Chip Models of Bone Metastasis.Front Med Technol. 2021 Sep 1;3:722501. doi: 10.3389/fmedt.2021.722501. eCollection 2021. Front Med Technol. 2021. PMID: 35047952 Free PMC article. Review.
-
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.Biochem J. 1996 Jul 1;317 ( Pt 1)(Pt 1):59-64. doi: 10.1042/bj3170059. Biochem J. 1996. PMID: 8694787 Free PMC article.
-
Bone mineralisation and glucose metabolism.Curr Opin Endocr Metab Res. 2023 Apr;29:100446. doi: 10.1016/j.coemr.2023.100446. Curr Opin Endocr Metab Res. 2023. PMID: 39184263 Free PMC article. Review.
-
Dynamic light scattering study of inhibition of nucleation and growth of hydroxyapatite crystals by osteopontin.PLoS One. 2013;8(2):e56764. doi: 10.1371/journal.pone.0056764. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457612 Free PMC article.
-
Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency.PLoS One. 2015 Jan 20;10(1):e0117098. doi: 10.1371/journal.pone.0117098. eCollection 2015. PLoS One. 2015. PMID: 25603410 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials